Files in this Data Supplement:

• Supplemental file 1 - Fig. S1. Results from four replicate plates from a high-throughput screen of known biologicals are shown. Fig. S2. Compound treatment does not downregulate Gb3 receptor expression. Fig. S3. Both compounds 134 and 75 disrupt Golgi network architecture. Fig. S4. Compounds 75 and 134 alter the kinetics of GFP secretion.
  Zipped PDF document, 320K.
• Supplemental file 2 - Legends to supplemental figures.
  MS Word document, 30K.